PharmaBoardroom

Jacqueline Anastassiades has been involved in the development of the Cypriot healthcare sector for more than 10 years as the Managing…

Dr. Qiu, could you please introduce your company, H-Guard, to our international readers? "It is clear that our efforts and investments over the past…

Simon, you established Glory Medical back in 1998. What was the main rationale behind this significant decision? "We already have operations in Sri…

Peter Burema, CEO of NextPharma, explains the specificities of a UK-based CDMO with manufacturing sites on the European continent. He describes how…

The managing director of the Spanish affiliate of one of France’s most exciting and ambitious mid-caps speaks out about crafting a commercial…

Laura McMullin, General Manager of the pharmaceutical division of Pierre Fabre in the UK and Ireland, explains the huge untapped potential of the…

With four out of the five NHS bodies, Leeds City Region is strongly anchored in the British life sciences ecosystem. Chair of Leeds City Region…

Alba Ancochea of FEDER, the association that groups together Spain’s 337 rare disease patient organizations, explains how it interacts with both…

Thembalath Ramachandran, chairman and managing director of one of the UK’s fastest growing generics manufacturers, Bristol Laboratories, describes…

Bahadir Kaleagasi, secretary general of the Turkish Industry & Business Association (TÜSIAD) discusses the strengths of the country as Europe’s…

Philip Lews Williams, managing director of the UK affiliate of French ophthalmology specialist Théa, describes the evolution of the company’s…

Having just announced a major investment into a new UK Discovery Centre in London that is set to open in 2020, MSD is committed to leverage on the…